Terms: = Germ cell tumor AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Diagnosis
194 results:
1. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
2. GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning.
Zheng S; Rammohan N; Sita T; Teo PT; Wu Y; Lesniak M; Sachdev S; Thomas TO
Sci Rep; 2024 Jan; 14(1):2126. PubMed ID: 38267516
[TBL] [Abstract] [Full Text] [Related]
3. Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
On J; Natsumeda M; Takahashi H; Koyama A; Shibuma S; Shibata N; Watanabe J; Saito S; Kanemaru Y; Tsukamoto Y; Okada M; Ogura R; Eda T; Tada M; Shimizu H; Adachi JI; Mishima K; Nishikawa R; Kakita A; Oishi M
J Neurooncol; 2024 Jan; 166(2):273-282. PubMed ID: 38227143
[TBL] [Abstract] [Full Text] [Related]
4. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
[TBL] [Abstract] [Full Text] [Related]
5. Differential cell cycle checkpoint evasion by pten germline mutations associated with dichotomous phenotypes of cancer versus autism spectrum disorder.
Hitomi M; Venegas J; Kang SC; Eng C
Oncogene; 2023 Dec; 42(50):3698-3707. PubMed ID: 37907589
[TBL] [Abstract] [Full Text] [Related]
6. Clinical and Proteomic-Based Molecular Characterizations of Invasive and Noninvasive Somatotroph PitNETs.
Chen M; Duan L; Sun W; Guo Z; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
Neuroendocrinology; 2023; 113(9):971-986. PubMed ID: 37253344
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA-PVT1 was identified as a key regulator for TMZ resistance and STAT-related pathway in glioma.
Chen Y; Ma F; Zhang Z; Guo Y; Shen H; Chen H
BMC Cancer; 2023 May; 23(1):455. PubMed ID: 37202742
[TBL] [Abstract] [Full Text] [Related]
8. Longitudinal Analysis of Cancer Risk in Children and Adults With germline pten Variants.
Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
[TBL] [Abstract] [Full Text] [Related]
9.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract] [Full Text] [Related]
10. Acinar cell carcinoma with PRKAR1A and pten alterations and paraneoplastic panniculitis.
Yang Z; Zarate Rodriguez JG; Beck H; Byrnes K; Trikalinos NA; Hammill CW
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36549753
[TBL] [Abstract] [Full Text] [Related]
11. [Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
[No Abstract] [Full Text] [Related]
12. Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.
Kapteijn MY; Kaptein FHJ; Stals MAM; Klaase EE; García-Ortiz I; van Eijk R; Ruano D; van Duinen SG; Cannegieter SC; Taphoorn MJB; Dirven L; Koekkoek JAF; Klok FA; Versteeg HH; Buijs JT
Thromb Res; 2023 Jan; 221():10-18. PubMed ID: 36435047
[TBL] [Abstract] [Full Text] [Related]
13. Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma.
Zhou X; Rong R; Xiong S; Song W; Ji D; Xia X
Front Immunol; 2022; 13():914108. PubMed ID: 36032150
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel.
Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Fujio S; Kirishima M; Takigawa K; Hata N; Toh K; Yamamoto J; Hanaya R; Tanimoto A; Yoshimoto K
Neurol Med Chir (Tokyo); 2022 Sep; 62(9):391-399. PubMed ID: 36031351
[TBL] [Abstract] [Full Text] [Related]
15. Coexisting lipomatous meningioma and glioblastoma in Cowden syndrome: A unique tumor association.
Prieto R; Hofecker V; Corbacho C
Neuropathology; 2023 Feb; 43(1):110-116. PubMed ID: 36003032
[TBL] [Abstract] [Full Text] [Related]
16. tumor predisposition: what's the skin got to do with it?
Stacy A; Shinawi M; Coughlin CC
Curr Opin Pediatr; 2022 Aug; 34(4):349-358. PubMed ID: 35836394
[TBL] [Abstract] [Full Text] [Related]
17. Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations.
Solomon DA; Ramani B; Eiger-Moscovich M; Milman T; Uludag G; Crawford JB; Phan I; Char DH; Shields CL; Eagle RC; Bastian BC; Bloomer MM; Pekmezci M
Ophthalmology; 2022 Dec; 129(12):1429-1439. PubMed ID: 35835335
[TBL] [Abstract] [Full Text] [Related]
18. POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC.
Baine MK; Febres-Aldana CA; Chang JC; Jungbluth AA; Sethi S; Antonescu CR; Travis WD; Hsieh MS; Roh MS; Homer RJ; Ladanyi M; Egger JV; Lai WV; Rudin CM; Rekhtman N
J Thorac Oncol; 2022 Sep; 17(9):1109-1121. PubMed ID: 35760287
[TBL] [Abstract] [Full Text] [Related]
19. Case Report: Giant Paraganglioma of the Skull Base With Two Somatic Mutations in
Main AM; Benndorf G; Feldt-Rasmussen U; Fugleholm K; Kistorp T; Loya AC; Poulsgaard L; Rasmussen ÅK; Rossing M; Sølling C; Klose MC
Front Endocrinol (Lausanne); 2022; 13():857504. PubMed ID: 35498434
[TBL] [Abstract] [Full Text] [Related]
20. Metastatic Melanoma to a Neurofibroma.
Ireland A; Williams B; Rijhumal A; Mesbah Ardakani N
Am J Dermatopathol; 2022 Sep; 44(9):683-686. PubMed ID: 35475788
[TBL] [Abstract] [Full Text] [Related]
[Next]
